JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
large cell lymphoma; diffuse mixed histiocytic and lymphocytic lymphoma; follicular B cell lymphoma; B cell lymphoma
Established from the peritoneal effusion of a 43-year-old man with B-cell non-Hodgkin lymphoma (B-NHL), described at the time as diffuse, mixed small and large cell type; cell line carries EZH2 Y641N mutation; assigned to GCB-like lymphoma subtype (germinal center B-cell)
Homo sapiens Tissue:Peritoneal effusion Morphology:Lymphoblast-like Properties: Small single cells and in clusters, in suspension Cytogenic data: Human hyperdiploid karyotype with 2% polyploidy - 47(42-48)< 2n> X, -Y, +6, +7, del(4)(q23), del(6)(p21.3p22.2), i(6p), del(7)(q?22q?32), der(8)t(8; 9)(q24; p13), der(9)t(8; 19; 9)(q24; q13; p13), dup(11)(q24q25), t(14; 18)(q32; q21), der(22)t(?7; 22)(?q32; p11) - sideline with dic(8; 9)(q24; p13), ider(8)(q10)t(8; 9(q24; p13) - matches published karyotype - carries t(14; 18) effecting IGH-BCL2 fusion Patient: Male, Caucasian, 43 yrs of age Medium: RPMI-1640 Medium + 10% FBS Subculture: Cultures can be maintained by the addition of fresh medium. Seed cells at 8 X 104 to 3 x 10^5 cells/mL is recommended. Subculture when cell concentration is between 7 x 105 and 1 x 10^6 cells/mL; a certain amount of cell debris is always visible; A subcultivation ratio of 1:3 to 1:4 is recommended.5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): D5S818: 12; D13S317: 12, 14; D7S820: 10; D16S539: 11, 12; vWA: 14, 17; THO1: 6, 9.3; TPOX: 11, 12; CSF1PO: 10; Amelogenin: X
Peritoneal effusion Morphology:Lymphoblast-like Properties: Small single cells and in clusters, in suspension Cytogenic data: Human hyperdiploid karyotype with 2% polyploidy - 47(42-48)< 2n> X, -Y, +6, +7, del(4)(q23), del(6)(p21.3p22.2), i(6p), del(7)(q?22q?32), der(8)t(8; 9)(q24; p13), der(9)t(8; 19; 9)(q24; q13; p13), dup(11)(q24q25), t(14; 18)(q32; q21), der(22)t(?7; 22)(?q32; p11) - sideline with dic(8; 9)(q24; p13), ider(8)(q10)t(8; 9(q24; p13) - matches published karyotype - carries t(14; 18) effecting IGH-BCL2 fusion Patient: Male, Caucasian, 43 yrs of age Medium: RPMI-1640 Medium + 10% FBS Subculture: Cultures can be maintained by the addition of fresh medium. Seed cells at 8 X 104 to 3 x 10^5 cells/mL is recommended. Subculture when cell concentration is between 7 x 105 and 1 x 10^6 cells/mL; a certain amount of cell debris is always visible; A subcultivation ratio of 1:3 to 1:4 is recommended.5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): D5S818: 12; D13S317: 12, 14; D7S820: 10; D16S539: 11, 12; vWA: 14, 17; THO1: 6, 9.3; TPOX: 11, 12; CSF1PO: 10; Amelogenin: X
Lymphoblast-like Properties: Small single cells and in clusters, in suspension Cytogenic data: Human hyperdiploid karyotype with 2% polyploidy - 47(42-48)< 2n> X, -Y, +6, +7, del(4)(q23), del(6)(p21.3p22.2), i(6p), del(7)(q?22q?32), der(8)t(8; 9)(q24; p13), der(9)t(8; 19; 9)(q24; q13; p13), dup(11)(q24q25), t(14; 18)(q32; q21), der(22)t(?7; 22)(?q32; p11) - sideline with dic(8; 9)(q24; p13), ider(8)(q10)t(8; 9(q24; p13) - matches published karyotype - carries t(14; 18) effecting IGH-BCL2 fusion Patient: Male, Caucasian, 43 yrs of age Medium: RPMI-1640 Medium + 10% FBS Subculture: Cultures can be maintained by the addition of fresh medium. Seed cells at 8 X 104 to 3 x 10^5 cells/mL is recommended. Subculture when cell concentration is between 7 x 105 and 1 x 10^6 cells/mL; a certain amount of cell debris is always visible; A subcultivation ratio of 1:3 to 1:4 is recommended.5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): D5S818: 12; D13S317: 12, 14; D7S820: 10; D16S539: 11, 12; vWA: 14, 17; THO1: 6, 9.3; TPOX: 11, 12; CSF1PO: 10; Amelogenin: X
Small single cells and in clusters, in suspension Cytogenic data: Human hyperdiploid karyotype with 2% polyploidy - 47(42-48)< 2n> X, -Y, +6, +7, del(4)(q23), del(6)(p21.3p22.2), i(6p), del(7)(q?22q?32), der(8)t(8; 9)(q24; p13), der(9)t(8; 19; 9)(q24; q13; p13), dup(11)(q24q25), t(14; 18)(q32; q21), der(22)t(?7; 22)(?q32; p11) - sideline with dic(8; 9)(q24; p13), ider(8)(q10)t(8; 9(q24; p13) - matches published karyotype - carries t(14; 18) effecting IGH-BCL2 fusion Patient: Male, Caucasian, 43 yrs of age Medium: RPMI-1640 Medium + 10% FBS Subculture: Cultures can be maintained by the addition of fresh medium. Seed cells at 8 X 104 to 3 x 10^5 cells/mL is recommended. Subculture when cell concentration is between 7 x 105 and 1 x 10^6 cells/mL; a certain amount of cell debris is always visible; A subcultivation ratio of 1:3 to 1:4 is recommended.5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): D5S818: 12; D13S317: 12, 14; D7S820: 10; D16S539: 11, 12; vWA: 14, 17; THO1: 6, 9.3; TPOX: 11, 12; CSF1PO: 10; Amelogenin: X
Human hyperdiploid karyotype with 2% polyploidy - 47(42-48)< 2n> X, -Y, +6, +7, del(4)(q23), del(6)(p21.3p22.2), i(6p), del(7)(q?22q?32), der(8)t(8; 9)(q24; p13), der(9)t(8; 19; 9)(q24; q13; p13), dup(11)(q24q25), t(14; 18)(q32; q21), der(22)t(?7; 22)(?q32; p11) - sideline with dic(8; 9)(q24; p13), ider(8)(q10)t(8; 9(q24; p13) - matches published karyotype - carries t(14; 18) effecting IGH-BCL2 fusion Patient: Male, Caucasian, 43 yrs of age Medium: RPMI-1640 Medium + 10% FBS Subculture: Cultures can be maintained by the addition of fresh medium. Seed cells at 8 X 104 to 3 x 10^5 cells/mL is recommended. Subculture when cell concentration is between 7 x 105 and 1 x 10^6 cells/mL; a certain amount of cell debris is always visible; A subcultivation ratio of 1:3 to 1:4 is recommended.5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): D5S818: 12; D13S317: 12, 14; D7S820: 10; D16S539: 11, 12; vWA: 14, 17; THO1: 6, 9.3; TPOX: 11, 12; CSF1PO: 10; Amelogenin: X
Male, Caucasian, 43 yrs of age Medium: RPMI-1640 Medium + 10% FBS Subculture: Cultures can be maintained by the addition of fresh medium. Seed cells at 8 X 104 to 3 x 10^5 cells/mL is recommended. Subculture when cell concentration is between 7 x 105 and 1 x 10^6 cells/mL; a certain amount of cell debris is always visible; A subcultivation ratio of 1:3 to 1:4 is recommended.5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): D5S818: 12; D13S317: 12, 14; D7S820: 10; D16S539: 11, 12; vWA: 14, 17; THO1: 6, 9.3; TPOX: 11, 12; CSF1PO: 10; Amelogenin: X
RPMI-1640 Medium + 10% FBS Subculture: Cultures can be maintained by the addition of fresh medium. Seed cells at 8 X 104 to 3 x 10^5 cells/mL is recommended. Subculture when cell concentration is between 7 x 105 and 1 x 10^6 cells/mL; a certain amount of cell debris is always visible; A subcultivation ratio of 1:3 to 1:4 is recommended.5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): D5S818: 12; D13S317: 12, 14; D7S820: 10; D16S539: 11, 12; vWA: 14, 17; THO1: 6, 9.3; TPOX: 11, 12; CSF1PO: 10; Amelogenin: X
Cultures can be maintained by the addition of fresh medium. Seed cells at 8 X 104 to 3 x 10^5 cells/mL is recommended. Subculture when cell concentration is between 7 x 105 and 1 x 10^6 cells/mL; a certain amount of cell debris is always visible; A subcultivation ratio of 1:3 to 1:4 is recommended.5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): D5S818: 12; D13S317: 12, 14; D7S820: 10; D16S539: 11, 12; vWA: 14, 17; THO1: 6, 9.3; TPOX: 11, 12; CSF1PO: 10; Amelogenin: X
Complete culture medium supplemented with 5% (v/v) DMSO
I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): D5S818: 12; D13S317: 12, 14; D7S820: 10; D16S539: 11, 12; vWA: 14, 17; THO1: 6, 9.3; TPOX: 11, 12; CSF1PO: 10; Amelogenin: X
Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): D5S818: 12; D13S317: 12, 14; D7S820: 10; D16S539: 11, 12; vWA: 14, 17; THO1: 6, 9.3; TPOX: 11, 12; CSF1PO: 10; Amelogenin: X
Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): D5S818: 12; D13S317: 12, 14; D7S820: 10; D16S539: 11, 12; vWA: 14, 17; THO1: 6, 9.3; TPOX: 11, 12; CSF1PO: 10; Amelogenin: X
Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): D5S818: 12; D13S317: 12, 14; D7S820: 10; D16S539: 11, 12; vWA: 14, 17; THO1: 6, 9.3; TPOX: 11, 12; CSF1PO: 10; Amelogenin: X
HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): D5S818: 12; D13S317: 12, 14; D7S820: 10; D16S539: 11, 12; vWA: 14, 17; THO1: 6, 9.3; TPOX: 11, 12; CSF1PO: 10; Amelogenin: X
Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): D5S818: 12; D13S317: 12, 14; D7S820: 10; D16S539: 11, 12; vWA: 14, 17; THO1: 6, 9.3; TPOX: 11, 12; CSF1PO: 10; Amelogenin: X
Hepatitis C: Negative DNA Profile (STR): D5S818: 12; D13S317: 12, 14; D7S820: 10; D16S539: 11, 12; vWA: 14, 17; THO1: 6, 9.3; TPOX: 11, 12; CSF1PO: 10; Amelogenin: X
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!